From 2012-2015 there was a 13% increase in pharmaceutical revenue loss amounting to an estimated $637 billion globally on an annual basis. According to an updated report by CapGemini and HealthPrize Technologies, this loss is directly attributed to medication nonadherence. This persistent issue has only grown despite new healthcare stakeholder policies, programs and incentive programs. […]
December 12, 2016 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - In November CapGemini and HealthPrize Technologies updated the forward to a reissued 2012 report on pharmaceutical revenue loss due to medication nonadherence that states, “Globally, according to CMR International, pharma revenues hit $1.1 trillion in 2015, which is a 13% increase […]
December 8, 2016 - Curant Health COO, Marc O'Connor, in Specialty Pharmacy Times The Status of HIV Medication Adherence and Viral Load Suppression At the end of 2010, the American South accounted for 45% of the estimated 33,015 new AIDS diagnoses in the 50 states and the District of Columbia, followed by the Northeast (24%), […]
November 16, 2016 - Atlanta & Houston - DiabetesAmerica, a provider of healthcare services focused solely on diabetics, and Curant Health, a leading medication management company, announced today the launch of a pilot program intended to improve outcomes for diabetes patients. The short-term goals of the pilot are two-fold and incorporate Curant Health’s Patient Support […]
What do we know? We have long said that medication adherence is the influential lever that can lower healthcare waste, which ranges from $105 to $300 billion annually. However, without medication fill there can be no medication adherence. Studies have shown that the percentage of patients who never get their medications filled are between 28% […]
Despite the presidential outcomes, we in the healthcare industry will still be faced with a heavy issue: how to go about reining in drug costs. Focus on adherence in real-world conditions. Our C the Cure program for a cohort of hepatitis C patients co-infected with HIV resulted in 90% of the patients having a sustained […]
From ACG 2016 - First of its kind study by Johns Hopkins and Curant Health finds MTM increases adherence over 30 percent compared to the standard of care for patients with Inflammatory Bowel Disease. October 17, 2016 ATLANTA & LAS VEGAS--(BUSINESS WIRE)--Curant Health, provider of enhanced medication therapy management and specialty pharmacy services, and Johns […]
October 13, 2016 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - Adherence in real-world conditions, streamlining prior authorizations and securing stakeholder buy in on the price/value curve can reign in drug spending no matter who becomes president. Here are three ways to help reign in drug costs. 1. Focus on adherence in […]
Study evaluates the Impact of Trough Level-Based Infliximab Dosing on Clinical and Endoscopic Remissions in Patients with IBD October 13, 2016 (Atlanta and Chicago) - Northwestern University Feinberg School of Medicine and Curant Health have announced a new prospective study entitled, “A Collaborative Study to Evaluate the Efficacy of Prospective Post-Induction Infliximab Dosing Based on […]
Every year, biotech industry leaders throughout the southeastern United States convene at Georgia Bio’s flagship conference. Georgia Bio 2016 was no different as hundreds of professionals representing pharmaceutical manufacturers, patient advocacy groups, innovative growth stage companies, service providers and academic institutions met at the Cobb Galleria Center on September 28th. Gatherings like Georgia Bio provide […]
